Vanda Pharmaceuticals
VNDA
VNDA
187 hedge funds and large institutions have $603M invested in Vanda Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 74 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% less capital invested
Capital invested by funds: $850M → $603M (-$247M)
29% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 31
Holders
187
Holding in Top 10
–
Calls
$1.02M
Puts
$735K
Top Buyers
| 1 | +$9.94M | |
| 2 | +$8.32M | |
| 3 | +$6.99M | |
| 4 |
Millennium Management
New York
|
+$4.46M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$4.17M |
Top Sellers
| 1 | -$7.84M | |
| 2 | -$3.88M | |
| 3 | -$2.52M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$2.49M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$2.21M |